← Back

HealthCap

Europe HQ Seed Series-A Above Series A
Last updated 16 Oct 2026 Website ↗
Latest fund: undisclosed size · announced Aug 2025✓ Community-verified
Cheque range
(undisclosed)
Stages
Seed, Series A, Above Series A
Avg deals / year
–
Leads rounds
Yes
HQ
Stockholm, Sweden
Fund type
Venture fund
Last fund raised
2025-08

01 · Thesis & focus

HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996. It invests globally in breakthrough therapies for diseases with high unmet medical need, and its site lists 138 portfolio companies financed. Its ninth fund, HealthCap IX, held a final close above target in August 2025, and recent rounds include co-leading Series A rounds in Altay Therapeutics and CurifyLabs.

Sectors (2)
Life Sciences Healthcare & Wellbeing

02 · Recent publicly announced deals

AMRA Medical 🇸🇪 Venture round (HealthCap investment) · Sep 2026 announcement ↗ site ↗

Linköping, Sweden health-informatics company offering MRI-based fat and muscle biomarker analysis for clinical research and care.

Founders: Magnus B.
CurifyLabs 🇫🇮 Series A · Jul 2026 · $14M First-cheque stage announcement ↗

Finnish pharmacy-compounding technology company; Series A co-led by Sandwater and HealthCap to fund scaling, including US expansion.

Founders: Niklas S., Charlotta T., Mika P.
Adcendo 🇩🇰 Series C · Apr 2026 First-cheque stage site ↗

Developing next-generation antibody-drug conjugates for cancers with high unmet need. Copenhagen area, Denmark.

Founders: Henrik S., Niels B.
Positrigo 🇨🇭 Series B · Oct 2025 First-cheque stage site ↗

Ultra-compact brain PET scanner for accessible dementia and Alzheimer's diagnosis. Zurich.

Founders: Jannis F., Max A.
Priothera 🇫🇷 Series A · Sep 2025 First-cheque stage site ↗

Immune modulator to improve outcomes of allogeneic stem cell transplantation in blood cancers. Saint-Louis, France.

Founders: Florent G., Dr. S., Christoph B.
Tribune Therapeutics 🇸🇪 Series A · Mar 2025 · €23M First-cheque stage announcement ↗

Nordic biotech developing CCN5-mimicking anti-fibrotic therapies (lead TRX-44 for IPF)

Founders: Ole K.
HelloBetter 🇩🇪 Series A · Mar 2025 First-cheque stage site ↗

Evidence-based online therapy programmes (stress, sleep, anxiety, pain) available as prescription digital therapeutics in Germany. Berlin.

Founders: Hannes K., Philip I., Amit G., Pierre C.
Adcendo 🇩🇰 Series B · Nov 2024 · $135M First-cheque stage announcement ↗

Copenhagen biotech developing first-in-class antibody-drug conjugates for cancer

Founders: Henrik S., Niels B.
Notable co-investorsIndustrifondenLifeline Ventures

03 · Similar firms

Longwall Venture Partners LLP
£1M – £10M · Also Seed · Life Sciences Maven Capital Partners
£1M – £20M · Also Seed · Life Sciences Oxford Innovation EIS Growth Fund
£150k – £400k · Also Seed · Life Sciences Ananda Impact Ventures
£5M – £15M · Also Seed · Life Sciences SCOR Ventures
£1M – £10M · Also Seed · Life Sciences Apollo Health Ventures
£1M – £20M · Also Seed · Life Sciences
Raising? See which European funds fit your round →